A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Song, J., Shi, J., Dong, D., Fang, M., Zhong, W., Wang, K., Wu, N., Huang, Y., Liu, Z., Cheng, Y., Gan, Y., Zhou, Y., Zhou, P., Chen, B., Liang, C., Liu, Z., Li, W., Tian, J.
The American Association for Cancer Research (AACR)
Published 2018